Over the last few decades there has been an increasing interest in analyzing the science of longevity. This reawakened interest is based in part on Nobel prize-winning discoveries. At Stanford, Dr. Helms\’ group works on understanding why healing rates slow as we age, and at Ankasa Regenerative Therapeutics, some of that ground-breaking bench science is being translated into therapeutic strategies to accelerate bone repair in older patients.